This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Davisson, R. L. Articles by Lewis, S. J. Search for Related Content PubMed PubMed Citation Articles by Davisson, R. L. Articles by Lewis, S. J.

(Hypertension. 1996;28:354-360.)
© 1996 American Heart Association, Inc.

Articles

Use-Dependent Loss of Acetylcholine- and Bradykinin-Mediated Vasodilation After Nitric Oxide Synthase Inhibition

Evidence for Preformed Stores of Nitric Oxide–Containing Factors in Vascular Endothelial Cells

Robin L. Davisson; James N. Bates; A. Kim Johnson; Stephen J. Lewis

the Cardiovascular Center and Departments of Pharmacology (R.L.D., A.K.J., S.J.L.), Anesthesia (J.N.B.), and Psychology (A.K.J.), The University of Iowa, Iowa City.

Correspondence to Stephen J. Lewis, PhD, Department of Pharmacology, 2-210 Bowen Science Bldg, The University of Iowa, Iowa City, IA 52242.

In the present study, we examined the possibility that the endothelium-dependent vasodilators acetylcholine and bradykinin release preformed pools of nitric oxide–containing factors. Successive injections of selected doses of acetylcholine (1.18±0.3 µg/kg IV) or bradykinin (5 µg/kg IV) caused reproducible hypotensive and vasodilator responses within sympathetically intact and sympathetically denervated hindlimbs of conscious rats. After administration of the nitric oxide synthesis inhibitor N-nitro-L-arginine methyl ester (L-NAME, 25 µmol/kg IV), the first injection of acetylcholine or bradykinin produced pronounced depressor and vasodilator responses that, in the case of bradykinin, were greater than those observed before L-NAME administration. However, each successive injection of acetylcholine and bradykinin produced progressively smaller responses, such that the later injections elicited a markedly diminished hypotension and vasodilation. This "use-dependent" loss of endothelium-dependent vasodilation was not due to the diminished vasorelaxant potency of nitric oxide–containing factors because the vasodilator effects of the nitric oxide donor sodium nitroprusside (32 µg/kg IV) and the S-nitrosothiol compound S-nitrosocysteine (200 nmol/kg IV) were augmented in the presence of L-NAME. These results suggest that the use-dependent loss of the hemodynamic effects of acetylcholine and bradykinin in L-NAME–treated rats may be due to the release and subsequent depletion of a factor whose synthesis depends on the bioavailability of nitric oxide. Taken together, these results suggest that preformed pools of nitric oxide–containing factors exist within the endothelium of resistance vessels and that endothelium-dependent agonists exert their vasorelaxant effects at least in part by the mobilization of these preformed pools.

Key Words: acetylcholine • bradykinin • endothelium-derived factor • hemodynamics • nitric oxide • rats

This article has been cited by other articles:

				M. T. Forrester, M. W. Foster, and J. S. Stamler Assessment and Application of the Biotin Switch Technique for Examining Protein S-Nitrosylation under Conditions of Pharmacologically Induced Oxidative Stress J. Biol. Chem., May 11, 2007; 282(19): 13977 - 13983. [Abstract] [Full Text] [PDF]

				O. S. Possas, A. K. Johnson, and S. J. Lewis Role of nitrosyl factors in the hindlimb vasodilation elicited by baroreceptor afferent nerve stimulation Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R741 - R748. [Abstract] [Full Text] [PDF]

				W. W. Batenburg, I. M. Garrelds, J. P. van Kats, P. R. Saxena, and A. H. J. Danser Mediators of Bradykinin-Induced Vasorelaxation in Human Coronary Microarteries Hypertension, February 1, 2004; 43(2): 488 - 492. [Abstract] [Full Text] [PDF]

				E. J. Whalen, A. K. Johnson, and S. J. Lewis {beta}-Adrenoceptor Dysfunction After Inhibition of NO Synthesis Hypertension, September 1, 2000; 36(3): 376 - 382. [Abstract] [Full Text] [PDF]

				E. J. Whalen, A. K. Johnson, and S. J. Lewis Tachyphylaxis to PACAP-27 after inhibition of NO synthesis: a loss of adenylate cyclase activation Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1999; 277(5): R1453 - R1461. [Abstract] [Full Text] [PDF]

				S. J Duffy, G. New, R. W Harper, and I. T Meredith Metabolic vasodilation in the human forearm is preserved in hypercholesterolemia despite impairment of endothelium-dependent and independent vasodilation Cardiovasc Res, August 15, 1999; 43(3): 721 - 730. [Abstract] [Full Text] [PDF]

				J. E. da Silva-Santos and J. Assreuy Long-Lasting Changes of Rat Blood Pressure to Vasoconstrictors and Vasodilators Induced by Nitric Oxide Donor Infusion: Involvement of Potassium Channels J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 380 - 387. [Abstract] [Full Text]

				E. J. Whalen, M. D. Travis, A. K. Johnson, and S. J. Lewis Rapid tachyphylaxis to hemodynamic effects of PACAP-27 after inhibition of nitric oxide synthesis Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2117 - H2126. [Abstract] [Full Text] [PDF]

				B. Mayer, S. Pfeiffer, A. Schrammel, D. Koesling, K. Schmidt, and F. Brunner A New Pathway of Nitric Oxide/Cyclic GMP Signaling Involving S-Nitrosoglutathione J. Biol. Chem., February 6, 1998; 273(6): 3264 - 3270. [Abstract] [Full Text] [PDF]

				P. Carvalho, S. R. Johnson, and N. B. Charan Non-cAMP-mediated bronchial arterial vasodilation in response to inhaled beta -agonists J Appl Physiol, January 1, 1998; 84(1): 215 - 221. [Abstract] [Full Text] [PDF]